Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance

Gynecological Endocrinology

Volumn 23, Issue 11, 2007, Pages 619-624

  Machado, Rogério Bonassi ^a,b,d   Baracat, Edmund Chada ^a   Fernandes, César Eduardo ^a,c   Lakryc, Eli Marcelo ^a   De Lima, Geraldo Rodrigues ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Jundiaí Medical School   (Brazil)

^c FACULDADE DE MEDICINA DO ABC   (Brazil)

^d FACULDADE DE MEDICINA DE JUNDIAÍ   (Brazil)

Author keywords

Estrogens; Homocysteine; Hormone therapy; Menopause; Vascular resistance

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; HOMOCYSTEINE; PLACEBO;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VASCULAR RESISTANCE;

CAROTID ARTERY, COMMON; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; HOMOCYSTEINE; HUMANS; MENOPAUSE; MIDDLE AGED; NORETHINDRONE; PLACEBOS; PROSPECTIVE STUDIES; PULSATILE FLOW; VASCULAR RESISTANCE;

EID: 36248995936     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701581663     Document Type: Article

References (35)

1. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest 1976;58:1079-1082.
2. Robinson K. Homocysteine and vascular disease. Luxemburg: Commission of the European Communities; 1990.
3. Berg K, Malinow MR, Kierulf P, Upson B. Population variation and genetics of plasma homocysteine metabolism level. Clin Genet 1992;41:315-321.
4. Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy and enzymology. Arterioscler Thromb 1993;13:1253-1260.
5. Starkebaum G, Harlam JM. Endothelial cell injury due to cooper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-1376.
6. Harpel PC, Zhang X, Borth W. Homocysteine and hemostasy: pathogenic mechanism predisposition to thrombosis. J Nutr 1996;126(4 Suppl):1285S-1289S.
7. Falcón CR, Carreras LO. Hyperhomocisteinemia moderada: fisiopatologia de la lesion endotelial e implicación clinica. Sangre 1998;43:47-54.
8. Boers G, Smals A, Trijbels FJ, Leemarkers AI, Kloppenborg PW. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in reproductive years. J Clin Invest 1983;72:1971-1976.
9. Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992;22:79-87.
10. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
11. Wouters MGAJ, Moorrees EC, Van Der Mooren MJ, Blom HJ, Boers GHJ, Schellekens LA, Thomas CMG, Eskes TKAB. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801-805.
12. Kim MH, KIm E, Passen EL, Meyer J, Kang SS. Cortisol and estradiol: non genetic factors for hyperhomocysteinemia. Metabolism 1997;46:247-249.
13. Morris MS, Jacques PF, Selhub J, Rosenberg IH. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000;152:140-148.
14. Bruschi F, Daguati R, Parazzini F, Dal Pino D, Fiore V, Di Pace R, Melotti D, Moroni S, Maffioletti C, Rossi M, et al. Age, menopausal status and homocysteine levels in women around menopause. Eur J Obstet Gynecol Reprod Biol 2005;120:195-197.
15. Van der Mooren MJ, Mijatovic V, van Baal WM, Stehouwer CDA. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease. Maturitas 1998;30:27-36.
16. Man RY, Ting LK, Fan S, Lau MM, Siow YL, Chung YH, Karmin O. Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women. Mol Cell Biochem 2001;225:129-134.
17. Mijatovic V, Kenemans P, Netelenbos C, Jakobs C, Popp-Snijders C, Peters-Muller ER, van der Mooren MJ. Postmenopausal oral 17b-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil Steril 1998;69:876-882.
18. Mijatovic V, Kenemans P, Jakobs C, van Baal WM, Peters-Muller ER, van der Mooren MJ. A randomized controlled study of the effects of 17β-estradiol- dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998;91:432-436.
19. Van Baal WM, Smolders RGV, Van der Mooren MJ, Teerlink T, Kenemans P. Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol 1999;93:486-493.
20. Van der Mooren MJ, Wouters MG, Blom HJ, Schellekens LA, Eskes TK, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994;24:733-736.
21. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
22. Meyer WJ, Jaffe R. Basic principles of Doppler ultrasonography. In: Jaffe R, Warsof SL editors. Color Doppler imaging in obstetrics and gynecology. New York: McGraw-Hill; 1992. pp 1-15.
23. Van Der Mooren M, Demacker PNM, Blom HJ, Rijke YB, Rolland R. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women. Fertil Steril 1997;67:67-73.
24. Hak AE, Polderman KH, Westendorp ICD, Jakobs C, Hofman A, Witteman JCM, Stehouver CDA. Increased plasma homocysteine after menopause. Atherosclerosis 2000;149:163-168.
25. Madsen JS, Kristensen SR, Klitgaard NA, Bladbjerg EM, Abrahamsen B, Stilgren L, Jesperson J. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. Am J Obstet Gynecol 2002;187:33-39.
26. Evio S, Tiitinen A, Turpeinen U, Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil Steril 2000;74:1080-1083.
27. Farag NH, Barshop BA, Mills PJ. Effects of estrogen and psychological stress on plasma homocysteine levels. Fertil Steril 2003;79:256-260.
28. Kurtay G, Ozmen B. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2007;130:206-211.
29. Penotti M, Farina M, Castiglioni E, Gaffuri B, Barletta L, Gabrielli L, Vignali M. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study. Am J Obstet Gynecol 1996;175:606-611.
30. Cacciatore B, Paakkari I, Toivonen J, Tikkanen MJ, Ylikorkala O. Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow. Obstet Gynecol 1998;92:563-568.
31. Jackson S, Vyas S. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index. Br J Obstet Gynaecol 1998;105:408-412.
32. Lau TK, Wan D, Yim SF, Sanderson JE, Haines CJ. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women. Fertil Steril 1998;70:284-288.
33. Stamler JS, Osborne JA, Jarali O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-318.
34. Stamler JS, Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev 1996;54:1-30.
35. Domagala TB, Undas A, Libura M, Szczeklik A. Pathogenesis of vascular disease in hyperhomocysteinaemia. J Cardiovasc Risk 1998;5:239-247.